Global fund to fight AIDS, tuberculosis and malaria

An international conference calls for substantially increased funding to undertake basic research and start to fight the scourge of AIDS in the developing world.

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

It's hardly news that the best intentions of governments and the expertise of public health and infectious disease researchers have not succeeded in containing the AIDS epidemic in Africa and other parts of the developing world.

But in April 2001, when UN Secretary General Kofi Annan called for the establishment of a global fund on AIDS and health, hopes rose that the addition of a third critical element — major investment of funds in a coordinated international effort — could promote the integrated goals of controlling HIV and two major related diseases, tuberculosis and malaria.

In October 2001 in Baltimore, Maryland, the Johns Hopkins University Center for AIDS Research hosted a two-day conference that shed some light on whether this hope is warranted. Given that the UN has estimated the cost of preventing and treating AIDS alone in the developing world at 7 to 10 billion dollars annually, and that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Nancy Heneson

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours